Page 4 - Oxford University

Airlines get ready for Covid-19 vaccine journey ahead of inoculation drive

Government has asked airlines to get ready to transport 30 tonnes of vaccines immediately

Morocco approves use of AstraZeneca-Oxford University's Covid-19 vaccine

Morocco has approved the emergency use of the AstraZeneca Covid-19 vaccine, jointly developed with the UK's Oxford University

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

A shot at transparency

Approval to Covaxin raises many questions

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Next step on vaccines

Nationwide roll-out needs meticulous planning

SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report

He said that the vaccine will be rolled out in the next 7 to 10 days

Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world

Astra vaccine accounts for more than 40% of supplies going to low- and middle-income nations

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

UK becomes world's first nation to approve AstraZeneca-Oxford Covid vaccine

The government has today accepted the recommendation to authorise Oxford University/AstraZeneca's Covid-19 vaccine for use, the health ministry said

Nod for Covid vaccine in the next few days: Serum Institute's Poonawalla

SII has stockpiled 40-50 mn doses and is adding more every week. Most of these will come to India, as exporting would require fulfilling WHO's pre-qualification procedures

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, the report said

Oxford Covid vaccine may be first to get govt nod for emergency use: Report

The process of granting emergency use approval for Bharat Biotech''s COVID-19 vaccine ''Covaxin'' may take time as its phase 3 trials are still underway, while Pfizer is yet to make a presentation

India likely to approve AstraZeneca vaccine by next week: Sources

This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials

Serum Institute to seek nod for two full-dose regimen of Covishield

Suresh Jadhav, executive director of the Pune-based firm, said on Friday Serum was seeking approval from the Drug Controller General of India (DCGI) for the two-full dose regimen

AstraZeneca's Covid-19 vaccine 70.4% effective at preventing the infection

AstraZeneca's Covid-19 vaccine is safe and effective at preventing symptomatic infection and it protects against severe disease and hospitalisation, a study concluded

Serum seeks emergency use nod for Oxford's Covid-19 vaccine in India

According to the ICMR, the SII has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license it obtained from the DCGI

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose

Volunteer for Oxford's Covid-19 vaccine seeks Rs 5 crore compensation

Vaccine 'Covishield' is being manufactured by Pune-based Serum Institute of India

India Coronavirus Dispatch: Situation remains grim in national capital

Covid may impact vision of some patients, ethical dilemma of denying vaccine to trial participants, UP artisans start selling online-news relevant to India's fight against the pandemic